Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.47
Delayed Data
As of Mar 27
 +0.03 / +1.23%
Today’s Change
1.00
Today|||52-Week Range
8.46
-3.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues5.0M3.8M8.0M5.7M
 
 
 
 
 
Depreciation And Amortization56.0K31.0K20.0K--
 
 
 
 
 
Operating ExpensesGross Income4.9M3.7M----
 
 
 
General Expenses30.8M38.3M39.7M50.8M
 
 
 
 
 
Research And Development22.6M29.2M28.9M27.7M
 
 
 
 
 
Total Operating Expenses30.9M38.4M39.7M50.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.9M-34.6M-31.8M-45.0M
 
 
 
 
 
Extraordinary Credit5.7M0.0096.0K--
 
 
 
Extraordinary Charge0.00-7.5M----
 
 
Interest Expense On Debt--1.9M2.9M1.7M
 
 
 
 
Other Expenses0.0010.0K-4.0K3.8M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.1M-44.0M-34.6M-43.0M
 
 
 
 
 
Net Income-20.1M-44.0M-34.6M-43.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS46.4M48.1M52.2M60.1M
 
 
 
 
 
Shares To Calculate EPS Diluted46.4M48.1M52.2M61.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.43-$0.91-$0.66-$0.76
 
 
 
 
 
EPS Diluted-$0.43-$0.91-$0.66-$0.76
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account